News from Nashville & around the world
Graduate student Steven Wall Jr. and Ivelin Georgiev, PhD. Photo by Donn Jones by Bill Snyder Children are an underutilized source of potential antibody therapies to counteract the “ever-evolving” COVID-19 pandemic, according to researchers at…
Cody Stubblefield, RN, gives the first of two injections of an antibody combination to Caroline Davis to protect her from COVID-19. (photo by Donn Jones) by Bill Snyder On Dec. 22, Caroline Davis of Nashville…
by Bill Snyder On Wednesday, the U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which protects against COVID-19, discovered last year at Vanderbilt…
by Bill Snyder The global biopharmaceutical company AstraZeneca said Oct. 5 it has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt…
by Bill Snyder AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. On Oct. 9, AstraZeneca…
by Nancy Humphrey The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for…